Kymera Therapeutics, Inc.
KYMR
Clasificación en acciones
#2177
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Precio por acción
$114.06
Última sincronización: 2026-10-20
Capitalización bursátil
$9.38B
Cambio (1 día)
5.54%
Cambio (1 año)
95.57%
País
US
Comercio Kymera Therapeutics, Inc. (KYMR)
Categoría
Healthcare
Número de acciones en circulación de Kymera Therapeutics, Inc. (KYMR)
Número de acciones en circulación al June 2026: 98.18M
Según los últimos informes financieros y el precio de las acciones de Kymera Therapeutics, Inc., el número actual de acciones en circulación es 98.18M. Al final de December 2023, la empresa tenía 58.37M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Kymera Therapeutics, Inc. (KYMR) desde 2018 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 98.18M | 30.83% |
| 2024 | 75.04M | 28.58% |
| 2023 | 58.37M | 8.22% |
| 2022 | 53.93M | 12.39% |
| 2021 | 47.99M | 7.70% |
| 2020 | 44.56M | 0.06% |
| 2019 | 44.53M | 0.00% |
| 2018 | 44.53M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | 158.61% |
US
|
|
| 396.00M | 303.35% |
US
|
|
| 478.91M | 387.80% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -36.66% |
NL
|
